NIH Advisory Board Reconstituted
Members of the National Institutes of Health’s (NIH) newly reconstituted Scientific Management Review Board expressed strong concerns over the reform proposals put forth by congressional Republicans, calling them “depressing” and “alarming.” These proposals, which aim to increase oversight, streamline NIH’s bureaucracy and reduce its funding, were discussed during the board’s first meeting in nearly a decade. Board Chair Andrea Hayes Dixon, M.D., emphasized the need for the NIH to rebuild trust and improve communication with lawmakers, particularly Republicans, who are pushing for greater control over the agency’s structure and research priorities.
Under former NIH Director Francis Collins, the review board had become dormant, and its revival is seen as a response to Republican criticisms and calls for more accountability. The 2024 omnibus appropriations law included a provision to restart the board, which
was recently populated by members
appointed by Health and Human Services Secretary Xavier Becerra.
Reconstituting the review board was a key part of the GOP proposals released earlier this year by U.S. Sen. Bill Cassidy (R-LA), Ranking member of the Senate Health, Education, Labor and Pensions Committee, and U.S. Rep. Cathy McMorris Rodgers (R-WA), Chair of the House Energy and Commerce Committee.
As Cassidy is poised to become the Chair of the Senate Health, Education, Labor and Pensions Committee in January 2025, the future of NIH's oversight and structure remains a key point of contention. Rodgers is retiring from Congress, but her successor on the Energy and Commerce panel is expected to continue her push for more oversight and restructuring at NIH.